- Fellowship in 1992 at Royal Free Hospital
Prof James Chim is SH Ho Professor in Haematology & Oncology, Department of Medicine, University of Hong Kong, and Honorary Consultant, Queen Mary Hospital. He graduated from the faculty of Medicine, Chinese University of Hong Kong, and obtained his Doctor of Medicine & Doctor of Philosophy from the University of Hong Kong. Currently, he is a honorary fellow of the Royal Colleges of London, Edinburgh & Glasgow, and the American College of Physician. Moreover, he is also a fellow of the Royal College of Pathologist of United Kingdom and the founding member of the Faculty of Science, Royal College of Pathologists of Australia. He has been a research fellow in the Royal Free Hospital, London, and the University of Chicago. Currently, he is accredited for Haematology and Haematological Oncology by the HK College of Physicians, and Advanced Internal Medicine by the HK Academy of Medicine.
He is a clinician scientist interested in clinical and translational studies in haematological cancers. He has published 220 papers (being first author > 135) in peer-reviewed journals including Blood, Journal of Clinical Oncology, Leukemia & Nature Review of Clinical Oncology. Prof Chim is interested in the scientific research of DNA methylation of protein-coding genes and non-coding RNAs in haematological cancers, on which he has published 50 papers including seven reviews. Moreover, he is interested in clinical studies of multiple myeloma, lymphoma and leukemia. Based on his studies in epigenetic alterations in leukemia, Prof Chim was awarded the State Scientific and Technological Progress Award in 2009. He is currently Visiting Professor to multiple universities in mainland China.
Internationally, he is currently the Member of the International Myeloma Working Group (IMWG), Executive Committee member of the Asia Myeloma Network, member of the Epigenetics Society and Chairman of Education Program, Asia Pacific Hematology Consortium (APHCON). He is also the Founding Chairman of the Hong Kong Society of Myeloma. Moreover, he has also been the Consultant of Physicians’ Information and Education Resources (PIER), American College of Physicians from Jan 2008-Dec 2011, and Chairman of the Hong Kong Society of Haematology form 2003-2006.
He was an invited reviewer for Annual Scientific Meeting of the American Society of Hematology (ASH) in 2009, and has been the external reviewer for prestigious grant funding organizations including Leukaemia & Lymphoma Research, Leukemia Research (United Kingdom), Cancer Research United Kingdom, The Agency for Science, Technology and Research (A*Star) of Singapore, Association for International Cancer Research (AICR) and Czech Science Foundation.
Currently, he is the Editor-in-Chief of Journal of Genetics Study, Associate Editor of Hematology and Journal of Bioscience and Medicine, and is on the editorial board of multiple journals including Journal of Hematology & Oncology, Bone Marrow Transplantation, Journal of Translational Medicine, Translational Oncology, Epigenomics, PLoS ONE, Current Oncology Reports, and Carcinogenesis (2009-2011).